Furthermore, GSK‐3β can participate in AD pathogenesis by regulating multiple intracellular signaling pathways, interfering with Aβ deposition, tau protein hyperphosphorylation, nerve cell apoptosis, and neuroinflammatory response, and other mechanisms (Figure 4).54 This evidence concerns the gene GSK3B and Alzheimer disease.